Roflumilast Cream Eases Itch, Improves Quality of Life in Infants With AD, Caregivers Report

Roflumilast cream 0.05% (Zoryve, Arcutis) shows improvements in itch and quality of life plus reductions in symptoms for infants with atopic dermatitis (AD) and their families, according to new caregiver-reported outcomes data from the INTEGUMENT-INFANT trial presented at the American College of Allergy, Asthma & Immunology’s (ACAAI) Annual Scientific Meeting in Phoenix, AZ.